FrancophonIA/ELRC3.0 huggingface dataset:
English: If blood appears at the injection site, press lightly.
Slovenian: Če se na mestu injiciranja pojavi kri, na mesto rahlo pritisnite.
English: This should be kept in mind if treatment with the combination of pioglitazone and Xultophy is considered.
Slovenian: To je treba upoštevati pri načrtovanju zdravljenja s kombinacijo pioglitazona in zdravila Xultophy.
English: • Use Xultophy once each day, preferably at the same time every day.
Slovenian: • Zdravilo Xultophy uporabljajte enkrat na dan, najbolje vsak dan ob istem času.
English: Baseline, End of trial and change values are observed Last observation carried forward.
Slovenian: Vrednosti v izhodišču in na koncu preskušanja ter vrednosti sprememb so zadnje opažene vrednosti prenesene naprej (last observation carried forward).
English: Xultophy contains two active substances that help your body control your blood sugar:
Slovenian: Zdravilo Xultophy vsebuje dve učinkovini, ki telesu pomagata uravnavati koncentracijo krvnega sladkorja:
English: Xultophy which has been frozen must not be used.
Slovenian: Če je zdravilo Xultophy zmrznilo, se ga ne sme uporabiti.
English: Hallas Alle, Kalundborg, 4400, Denmark Novo Nordisk A/S
Slovenian: Hallas Allé, Kalundborg, 4400, Danska
English: See your doctor if they do not disappear after a few weeks.
Slovenian: Če ne minejo v nekaj tednih, obiščite svojega zdravnika.
English: It is important always to check the flow before you inject.
Slovenian: Zelo pomembno je, da pred injiciranjem zdravila vedno preverite pretok.
English: If the needle is blocked, you will not inject any medicine.
Slovenian: Če je igla zamašena, ne boste injicirali zdravila.
English: 48.7% of patients treated with Xultophy reached the HbA1c target of <7% without confirmed hypoglycaemic episodes.
Slovenian: 48,7 % bolnikov, zdravljenih z zdravilom Xultophy, je doseglo ciljno vrednost HbA1c < 7 % brez potrjenih hipoglikemij.
English: Important information about some of the ingredients of Xultophy
Slovenian: Pomembne informacije o nekaterih sestavinah zdravila Xultophy
English: This is a build-up of acid in the blood because the body is breaking down fat instead of sugar.
Slovenian: ker telo presnavlja maščobe namesto sladkorja.
English: If no drop appears, you will not inject any medicine, even though the dose counter may move.
Slovenian: Če se kapljica ne pojavi, zdravila ne boste injicirali, tudi če se števec odmerka premakne.
English: Frequency categories are defined as: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000) and not known
Slovenian: (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki
English: Tap the top of the pen gently a few times to let any air bubbles rise to the top.
Slovenian: Nekajkrat s prstom rahlo potrkajte po vrhu injekcijskega peresnika, da se bodo morebitni zračni mehurčki zbrali na vrhu.
English: • Low blood sugar (very common: may affect more than 1 in 10 people).
Slovenian: • prenizek krvni sladkor (zelo pogost neželeni učinek, ki se lahko pojavi pri več kot 1 od
English: It is not known if Xultophy passes into breast milk.
Slovenian: Ni znano, če zdravilo Xultophy prehaja v materino mleko.
English: This might be due to the slower increase in the dose of the liraglutide component during treatment initiation when using Xultophy as compared to using liraglutide alone.
Slovenian: To bi lahko bila posledica počasnejšega povečevanja odmerka liraglutida pri uvajanju zdravljenja z zdravilom Xultophy v primerjavi z uporabo liraglutida samega.
English: What you need to know before you use Xultophy Do not use Xultophy:
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Xultophy Ne uporabljajte zdravila Xultophy:
English: The dose selector changes the number of dose steps.
Slovenian: Izbirnik odmerka spreminja število odmernih korakov.
English: • The use of Xultophy is not recommended in patients with inflammatory bowel disease or delayed gastric emptying (diabetic gastroparesis).
Slovenian: • Uporaba zdravila Xultophy ni priporočljiva pri bolnikih z vnetno črevesno boleznijo ali zakasnelim praznjenjem želodca (diabetična gastropareza).
English: When your pen contains less than 50 dose steps, the dose counter stops at the number of dose steps left.
Slovenian: Ko injekcijski peresnik vsebuje manj kot 50 odmernih korakov, se števec odmerka ustavi na številu preostalih odmernih korakov.
English: Patients who forget a dose are advised to take it upon discovery and then resume their usual once-daily dosing schedule.
Slovenian: Bolniki, ki pozabijo odmerek, naj si zdravilo injicirajo, ko to ugotovijo, in potem nadaljujejo s predpisanim odmerjanjem enkrat na dan.
English: The MAH shall provide educational materials prior to launch targeting all physicians and nurses who are expected to be involved in the treatment and management of diabetic patients and all pharmacists who are expected to dispense Xultophy.
Slovenian: Imetnik dovoljenja za promet bo pred prihodom zdravila na trg zagotovil izobraževalno gradivo, namenjeno vsem zdravnikom in medicinskim sestram, ki bodo predvidoma vključeni v zdravljenje in vodenje sladkornih bolnikov, in vsem farmacevtom, ki bodo predvidoma izdajali zdravilo Xultophy.
English: Estimated ratio
Slovenian: Ocenjeno razmerje
English: If a drop of solution still does not appear, dispose of the pen and use a new one.
Slovenian: Če se kapljica raztopine še vedno ne pojavi, injekcijski peresnik zavrzite in uporabite novega.
English: Transfer from insulin glargine (100 units/mL)
Slovenian: Prehod z zdravljenja z insulinom glargin (100 enot/ml)
English: • sulfonamides - for infections
Slovenian: • sulfonamide - zdravila za zdravljenje okužb,
English: • Do not store your pen at temperatures above 30°C.
Slovenian: • Injekcijskega peresnika ne shranjujte pri temperaturah, višjih od
English: Following subcutaneous administration, the protracted action profile is based on three mechanisms: self-association, which results in slow absorption; binding to albumin; and higher enzymatic stability towards the dipeptidyl peptidase IV (DPP-IV) and neutral endopeptidase (NEP) enzymes, resulting in a long plasma half-life.
Slovenian: Podaljšan profil delovanja liraglutida po subkutani aplikaciji temelji na treh mehanizmih: samozdruževanju, ki upočasni absorpcijo, vezavi na albumin ter večji stabilnosti proti delovanju encimov dipeptidil-peptidaze IV (DPP-IV) in nevtralne endopeptidaze (NEP), kar ima za posledico dolg razpolovni čas v plazmi.
English: During use
Slovenian: Med uporabo
English: • Check the name and coloured label of your pen, to make sure that it contains Xultophy.
Slovenian: • Preverite ime in barvno nalepko na injekcijskem peresniku, da se prepričate, da res vsebuje zdravilo Xultophy.
English: Patients who are blind or have poor vision must be instructed to always get help/assistance from another person who has good vision and is trained in using the insulin device.
Slovenian: Slepim in slabovidnim bolnikom je treba pojasniti, da jim mora vedno pomagati oseba, ki dobro vidi in je usposobljena za uporabo injekcijskega peresnika.
English: Diarrhoea and vomiting were reported in 7.5% and 3.9% of patients, respectively.
Slovenian: O driski so poročali pri 7,5 % bolnikov, o bruhanju pa pri 3,9 % bolnikov.
English: Liraglutide N
Slovenian: liraglutid N
English: • If you are also taking a sulfonylurea (such as glimepiride or glibenclamide), your doctor may tell you to lower your sulfonylurea dose depending on your blood sugar levels.
Slovenian: • Če se sočasno zdravite s sulfonilsečnino (kot sta glimepirid ali glibenklamid), lahko zdravnik odmerek sulfonilsečnine zmanjša, odvisno od koncentracije krvnega sladkorja.
English: In rats, insulin degludec was secreted in milk; the concentration in milk was lower than in plasma.
Slovenian: Pri podganah se je insulin degludek izločal v mleko, koncentracija v mleku pa je bila manjša od koncentracije v plazmi.
English: Table 1 Adverse reactions reported in phase 3 controlled studies MedDRA System organ class Frequency
Slovenian: Preglednica 1: Neželeni učinki iz kontroliranih preskušanj 3. faze MedDRA organski sistem Pogostnost
English: The following substances may increase the Xultophy requirement: Oral contraceptives, thiazides, glucocorticoids, thyroid hormones, sympathomimetics, growth hormones and danazol.
Slovenian: Potrebo po zdravilu Xultophy lahko zvečajo naslednje učinkovine: peroralni kontraceptivi, tiazidi, glukokortikoidi, ščitnični hormoni, simpatikomimetiki, rastni hormoni in danazol.
English: You may stick yourself with the needle.
Slovenian: ker se lahko zbodete z iglo.
English: If you have a serious allergic reaction to any of the ingredients in Xultophy, stop using Xultophy and see a doctor straight away.
Slovenian: V primeru pojava resne alergijske reakcije na katero koli sestavino zdravila Xultophy prenehajte uporabljati zdravilo Xultophy in nemudoma poiščite zdravniško pomoč.
English: • water tablets called ‘thiazides' - for high blood pressure or if your body is holding onto too much water (water retention).
Slovenian: • zdravila za odvajanje vode iz telesa, imenovana tiazidi - uporabljajo se za zdravljenje visokega krvnega tlaka ali stanj, pri katerih telo zadržuje preveč vode v telesu (zastajanje vode).
English: If transferring from a long-acting GLP-1 receptor agonist (e.g. onceweekly dosing), the prolonged action should be considered.
Slovenian: Če bolnik prehaja z zdravljenja z dolgodelujočim agonistom receptorjev GLP-1 (npr. z odmerjanjem enkrat tedensko), je podaljšano delovanje zdravila treba upoštevati.
English: Patients must be advised to take precautions to avoid hypoglycaemia while driving.
Slovenian: Bolnikom je treba svetovati, da morajo upoštevati ustrezne previdnostne ukrepe, da med vožnjo vozila ne bi prišlo do hipoglikemije.
English: Xultophy contains less than 1 mmol sodium (23 mg) per dose, therefore the medicinal product is essentially ‘sodium-free'.
Slovenian: Zdravilo Xultophy vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar v bistvu pomeni “brez natrija”.
English: Patients whose blood glucose control is greatly improved (e.g. by intensified therapy) may experience a change in their usual warning symptoms of hypoglycaemia and must be advised accordingly.
Slovenian: Bolnikom, pri katerih se urejenost glikemije zelo izboljša (npr. z intenziviranim zdravljenjem), se običajni opozorilni simptomi hipoglikemije lahko spremenijo in jih je s to možnostjo treba seznaniti.
English: When Xultophy is added to sulfonylurea therapy, a reduction in the dose of sulfonylurea should be considered (see section 4.4).
Slovenian: Če se zdravilo Xultophy uporablja kot dodatek pri zdravljenju s sulfonilsečnino, je treba razmisliti o zmanjšanju odmerka sulfonilsečnine (glejte poglavje 4.4).
English: Xultophy can be added to existing oral antidiabetic treatment.
Slovenian: Zdravilo Xultophy se lahko uporablja kot dodatek k že obstoječemu zdravljenju s peroralnimi antidiabetiki.
English: Dose adjustments of griseofulvin and other compounds with low solubility and high permeability are not required.
Slovenian: Odmerka griseofulvina in drugih učinkovin z majhno topnostjo in veliko prepustnostjo ni treba prilagajati.
English: Acute pancreatitis has been observed with the use of GLP-1 receptor agonists, including liraglutide.
Slovenian: Akutni pankreatitis Akutni pankreatitis je bil opažen pri uporabi agonistov receptorjev GLP-1, vključno z liraglutidom.
English: The local tissue reactions in the two studies in rabbits and pigs, respectively, were limited to mild inflammatory reactions.
Slovenian: V študijah pri kuncih in prašičih so bile lokalne tkivne reakcije omejene na blage vnetne reakcije.
English: The differences are considered of no clinical relevance since Xultophy is initiated and titrated according to the individual patient's blood glucose targets.
Slovenian: Te razlike ne veljajo za klinično pomembne, saj se zdravilo Xultophy uvede in titrira v skladu s ciljnimi koncentracijami glukoze v krvi pri vsakem posameznem bolniku.
English: • The dose counter and the dose pointer show how many dose steps of Xultophy you select.
Slovenian: • Števec odmerka in kazalnik odmerka kažeta, koliko odmernih korakov zdravila Xultophy ste izbrali.
English: What Xultophy is and what it is used for What you need to know before you use Xultophy How to use Xultophy
Slovenian: Kaj je zdravilo Xultophy in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Xultophy Kako uporabljati zdravilo Xultophy
English: Insulin degludec N (%)
Slovenian: insulin degludek N (%)
English: Xultophy can be used in elderly patients but if you are elderly you may need to check your blood sugar level more often.
Slovenian: Zdravilo Xultophy se lahko uporablja pri starejših bolnikih, vendar pa morajo starejši bolniki pogosteje kontrolirati koncentracijo krvnega sladkorja.
English: Inadequate dosing and/or discontinuation of antidiabetic treatment may lead to hyperglycaemia and potentially to hyperosmolar coma.
Slovenian: Neustrezno odmerjanje in/ali prekinitev zdravljenja povzroči hiperglikemijo in morebiti tudi hiperosmolarno komo.
English: Solution for injection 1x3 mL
Slovenian: raztopina za injiciranje 1 x 3 ml
English: The cardiovascular safety of insulin degludec as compared to insulin glargine was confirmed (HR 0.91 [0.78; 1.06]) (Figure 7).
Slovenian: Varnost insulina degludek glede pojava srčno-žilnih dogodkov v primerjavi z insulinom glargin je bila potrjena (razmerje ogroženosti 0,91 [0,78; 1,06]) (Slika 7).
English: Xultophy must not be added to infusion fluids.
Slovenian: Zdravila Xultophy se ne sme dodajati infuzijskim tekočinam.
English: Transfer from basal insulin (NPH, insulin detemir, insulin glargine)
Slovenian: Prehod z zdravljenja z bazalnim insulinom (NPH, insulin detemir, insulin glargin)
English: Nausea was reported in 7.8% of patients and was transient in nature for most patients.
Slovenian: O navzei, ki je bila pri večini bolnikov prehodna, so poročali pri 7,8 % bolnikov.
English: Because of lack of experience, Xultophy should not be used during breast-feeding.
Slovenian: Zaradi pomanjkanja izkušenj se zdravila Xultophy med dojenjem ne sme uporabljati.
English: • liraglutide - a ‘GLP-1 analogue' that helps your body make more insulin during meals and lowers the amount of sugar made by your body.
Slovenian: • liraglutid - analog glukagonu podobnega peptida-1 (GLP-1), ki telesu pomaga proizvesti več insulina med obroki in znižuje količino v telesu nastalega sladkorja.
English: In six studies, Xultophy produced clinically and statistically significant improvements in glycaemic control versus comparators as measured by glycated haemaglobin A1c (HbA1c), whereas one study demonstrated a similar reduction of HbA1c in both treatment arms.
Slovenian: V šestih študijah je zdravilo Xultophy v primerjavi s primerjalnimi zdravili doseglo klinično pomembno in statistično značilno izboljšanje urejenosti glikemije, merjeno z glikiranim hemoglobinom A1c (HbA1c), v eni študiji pa je bilo znižanje HbA1c v obeh terapevtskih skupinah podobno.
English: You have diabetes because your body:
Slovenian: Sladkorna bolezen je posledica nezmožnosti telesa:
English: • Turn the dose selector to select 2 dose steps.
Slovenian: • Zavrtite izbirnik odmerka tako, da boste izbrali 2 odmerna koraka.
English: D The average pre-trial dose of insulin glargine was 32 units
Slovenian: D Povprečni odmerek insulina glargin pred preskušanjem je bil 32 enot.
English: • Xultophy is given as an injection under the skin (subcutaneously).
Slovenian: • Zdravilo Xultophy je namenjeno injiciranju pod kožo (subkutana uporaba).
English: Antibody formation has not been associated with reduced efficacy of Xultophy.
Slovenian: Nastanek protiteles ni bil povezan z zmanjšanjem učinkovitosti zdravila Xultophy.
English: The trial was designed as a non-inferiority trial to exclude a pre-specified risk margin of 1.3 for the hazard ratio (HR) of MACE comparing insulin degludec to insulin glargine.
Slovenian: Preskušanje je bilo načrtovano za ugotavljanje neinferiornosti, da bi izključili predhodno specificirano mejo tveganja 1,3 za razmerje ogroženosti za MACE pri primerjavi insulina degludek z insulinom glargin.
English: • insulin degludec - a long-acting basal insulin which lowers your blood sugar levels.
Slovenian: • insulin degludek - dolgodelujoči bazalni insulin, ki znižuje količino krvnega sladkorja in
English: • Dehydration (loss of fluid from the body) - it is important to drink plenty of fluids to stop dehydration.
Slovenian: • dehidracija (izguba vode iz telesa); za preprečitev dehidracije je pomembno, da pijete dovolj tekočine
English: Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.
Slovenian: Druga zdravila in zdravilo Xultophy Obvestite zdravnika, farmacevta ali medicinsko sestro, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
English: Do not inject it into a vein or muscle.
Slovenian: Zdravila nikoli ne smete injicirati v veno ali mišico.
English: There was no clinically relevant effect on the overall exposure of either ethinylestradiol or levonorgestrel.
Slovenian: Klinično pomembnega učinka na celokupno izpostavljenost etinilestradiolu ali levonorgestrelu ni bilo.
English: No studies have been conducted with the insulin degludec/liraglutide combination to evaluate carcinogenesis, mutagenesis or impairment of fertility.
Slovenian: Študij s kombinacijo insulina degludek/liraglutida, ki bi vrednotile karcinogenezo, mutagenezo ali vpliv na plodnost, niso izvedli.
English: Xultophy is for subcutaneous use only.
Slovenian: Zdravilo Xultophy je namenjeno zgolj subkutani uporabi.
English: Non-clinical studies with liraglutide have shown a treatment-related reduction of neonatal growth in suckling rat pups (see section 5.3).
Slovenian: Neklinične študije, izvedene z liraglutidom, so pokazale z uporabo zdravila povezano zmanjšanje neonatalne rasti pri dojenih mladičih podgan (glejte poglavje 5.3).
English: If the dose counter does not return to 0, the full dose has not been delivered, which may lead to high blood sugar level.
Slovenian: Če se števec odmerka ne vrne na 0, niste injicirali celotnega odmerka, posledično pa se lahko koncentracija krvnega sladkorja zveča.
English: HbA1c (%) at end of treatment
Slovenian: HbA1c (%) na koncu zdravljenja
English: • medicines called ‘sympathomimetics' such as epinephrine (adrenaline), salbutamol or terbutaline - for asthma
Slovenian: • zdravila, imenovana simpatikomimetiki (npr. adrenalin, salbutamol ali terbutalin) - uporabljajo se za zdravljenje astme,
English: Xultophy is to be dosed in accordance with the individual patient's needs.
Slovenian: Zdravilo Xultophy je treba odmerjati glede na potrebe posameznega bolnika.
English: In rare cases, the presence of such antibodies may necessitate adjustment of the Xultophy dose in order to correct a tendency to hyper- or hypoglycaemia.
Slovenian: V redkih primerih bo zaradi prisotnosti teh protiteles treba odmerek zdravila Xultophy prilagoditi, da bi odpravili nagnjenost k hiperglikemiji ali hipoglikemiji.
English: The advisability of driving should be considered in these circumstances.
Slovenian: V takšnih okoliščinah je treba presoditi, če je vožnja vozila sploh priporočljiva.
English: The prolonged effect of Xultophy may delay recovery from hypoglycaemia.
Slovenian: Podaljšani učinek zdravila Xultophy lahko upočasni okrevanje po hipoglikemiji.
English: Intensification of therapy with insulin, a component of Xultophy, with abrupt improvement in glycaemic control may be associated with temporary worsening of diabetic retinopathy, while longterm improved glycaemic control decreases the risk of progression of diabetic retinopathy.
Slovenian: Očesne bolezni Intenziviranje zdravljenja z insulinom, ene od sestavin zdravila Xultophy, s hitrim izboljšanjem urejenosti glikemije, lahko spremlja prehodno poslabšanje diabetične retinopatije, medtem ko dolgoročno izboljšanje urejenosti glikemije zmanjša tveganje za napredovanje diabetične retinopatije.
English: Omission of a meal or unplanned strenuous physical exercise may lead to hypoglycaemia.
Slovenian: Izpustitev obroka ali nenačrtovana, naporna telesna dejavnost lahko povzročita hipoglikemijo.
English: • Caregivers must be very careful when handling used needles - to prevent needle injury and cross-infection.
Slovenian: • Osebe, ki skrbijo za bolnika, morajo biti pri ravnanju z uporabljenimi iglami zelo pazljive, da se ne bi zbodle in okužile.
English: • You do not have to use Xultophy with a meal.
Slovenian: • Zdravila Xultophy ni treba uporabljati skupaj z obrokom.
English: • angiotensin converting enzyme (ACE) inhibitors - for some heart problems or high blood pressure.
Slovenian: • zaviralce angiotenzinske konvertaze (zaviralci ACE (angiotensin converting enzyme))zdravila za zdravljenje nekaterih bolezni srca ali visokega krvnega tlaka.
English: Do not stop using Xultophy without talking to your doctor.
Slovenian: Ne prenehajte uporabljati zdravila Xultophy, ne da bi se o tem prej posvetovali z zdravnikom.
English: • Do not use Xultophy if you have type 1 diabetes mellitus or if you have ‘ketoacidosis' (a condition with a build-up of acid in the blood).
Slovenian: • Ne uporabljajte zdravila Xultophy, če imate sladkorno bolezen tipa 1 ali “ketoacidozo” (stanje s kopičenjem kisline v krvi).
English: At baseline, HbA1c was 8.4% in both treatment groups and after 2 years HbA1c was 7.5% both with insulin degludec and insulin glargine.
Slovenian: V izhodišču je bil HbA1c 8,4 % v obeh skupinah in po 2 letih je bil HbA1c tako v skupini, ki je prejemala insulin degludek, kot v skupini, ki je prejemala insulin glargin, 7,5 %.
English: Apart from a slight decrease in the number of live implants, animal studies with liraglutide did not indicate harmful effects with respect to fertility.
Slovenian: Razen rahlega zmanjšanja števila živih ugnezdenj študije na živalih niso pokazale drugih škodljivih učinkov liraglutida na plodnost.
English: When Xultophy is used in patients with mild, moderate or severe renal impairment, glucose monitoring is to be intensified and the dose adjusted on an individual basis.
Slovenian: Če se zdravilo Xultophy uporablja pri bolnikih z blago, zmerno ali hudo okvaro ledvic, je treba koncentracijo glukoze v krvi spremljati pozorneje ter odmerek prilagoditi potrebam posameznega bolnika.
English: Always watch the dose counter to know how many dose steps you inject.
Slovenian: Vedno glejte števec odmerka, da vidite, koliko odmernih korakov injicirate.
English: • exercise more than usual
Slovenian: • jeste več kot ponavadi,
English: The MAH shall ensure that healthcare professionals are informed that all patients who have been prescribed Xultophy should be trained on the correct use of the prefilled pen before prescribing or dispensing Xultophy.
Slovenian: Imetnik dovoljenja za promet bo poskrbel za seznanitev zdravstvenih delavcev z dejstvom, da je treba vse bolnike usposobiti za pravilno uporabo napolnjenega injekcijskega peresnika, preden jim je zdravilo Xultophy predpisano ali izdano.
English: Interaction studies with Xultophy have not been performed.
Slovenian: Študij medsebojnega delovanja z zdravilom Xultophy niso izvedli.
English: Fast improvements in blood sugar control may make diabetic eye problems get worse for a short time.
Slovenian: Zaradi hitrega izboljšanja koncentracije krvnega sladkorja se lahko za kratek čas poslabšajo težave z očmi, ki so posledica sladkorne bolezni.
English: Table 4 Results at 26-weeks - Transfer from GLP-1 receptor agonists
Slovenian: Preglednica 4: Rezultati po 26 tednih - prehod z zdravljenja z agonisti receptorjev GLP-1
English: • Mild hypoglycaemic episodes can be treated by oral administration of glucose or other products containing sugar.
Slovenian: • Blage hipoglikemije se lahko zdravi z zaužitjem glukoze ali živil, ki vsebujejo sladkor.
English: Basal insulin and sulfonylurea/glinides were discontinued at randomisation.
Slovenian: Zdravljenje z bazalnim insulinom in sulfonilsečnino/glinidi so ukinili ob randomizaciji.